Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Synthetic Electrospun Fiber Matrix in Abdominal Wall Donor Sites for Breast Reconstruction

NCT: NCT07851415 · NOT_YET_RECRUITING

NCT IDNCT07851415
StatusNOT_YET_RECRUITING
Start Date2026-11-30
Completion2028-02-29
SponsorWashington University School of Medicine (OTHER)
First posted
Last updated

Brief Summary

This prospective single-arm pilot study will evaluate the application of meshed 5 × 7 cm Restrata® sheets to the abdominal wall donor site following deep inferior epigastric perforator (DIEP) or abdominal wall autologous free tissue transfer in 20 eligible patients.

Frequently Asked Questions

What is Synthetic Electrospun Fiber Matrix in Abdominal Wall Donor Sites for Breast Reconstruction?

Synthetic Electrospun Fiber Matrix in Abdominal Wall Donor Sites for Breast Reconstruction is a clinical trial registered under NCT07851415. Current status: NOT_YET_RECRUITING.

What is the status of NCT07851415?

The current status of NCT07851415 (Synthetic Electrospun Fiber Matrix in Abdominal Wall Donor Sites for Breast Reconstruction) is: NOT_YET_RECRUITING.

When did Synthetic Electrospun Fiber Matrix in Abdominal Wall Donor Sites for Breast Reconstruction start?

Synthetic Electrospun Fiber Matrix in Abdominal Wall Donor Sites for Breast Reconstruction started on 2026-11-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑